Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OSPOMYVâ„¢ (denosumab-dssb; SB16; 60 mg pre-filled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback